{
  "actions": [
    {
      "acted_at": "1980-06-18", 
      "committee": "House Committee on Interstate and Foreign Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to House Committee on Interstate and Foreign Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr7616-96", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Interstate and Foreign Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "96", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1980-06-18", 
  "number": "7616", 
  "official_title": "A bill to establish a national center for clinical pharmacology in the Department of Health and Human Services.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": "14", 
    "name": "Pepper, Claude", 
    "state": "FL", 
    "thomas_id": "00907", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1980-06-18", 
  "subjects": [
    "Department of Health and Human Services", 
    "Drug safety and regulation", 
    "Drugs and narcotics", 
    "Executive reorganization", 
    "Pharmaceutical research"
  ], 
  "subjects_top_term": "Pharmaceutical research", 
  "summary": {
    "as": "Introduced", 
    "date": "1980-06-18", 
    "text": "Establishes within the Department of Health and Human Services the National Center for Clinical Pharmacology under a Director appointed by the Secretary. Authorizes the Center to conduct and support research in clinical pharmacology and clinical pharmacy. Requires the Center to conduct an ongoing review and analysis of the use of drug products in the United States. Requires the Center to prepare an annual Drug Experience Assessment Report for the Secretary. Directs the Center to facilitate analysis of the consequences of State and Federal regulation of the manufacture, importation, exportation, and distribution of drug products, research activities and practices, and the practices of the pharmaceutical industry and health professionals respecting drug products. Requires the Director to periodically report to the Secretary on new techniques in research, areas where current research is insufficient, and promising new drugs in foreign countries."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "A bill to establish a national center for clinical pharmacology in the Department of Health and Human Services.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T18:45:23-05:00"
}